Published in Schweiz Med Wochenschr on July 13, 1968
Treatment of chronic portal-systemic encephalopathy with lactulose. Lancet (1966) 2.65
Increased activation of sympathetic nervous system and endothelin by mental stress in normotensive offspring of hypertensive parents. Circulation (1996) 2.05
Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure. Am J Med (1988) 1.66
Antihypertensive treatment and serum lipoproteins. J Hypertens (1985) 1.54
Insulin sensitivity and body fat distribution in normotensive offspring of hypertensive parents. Lancet (1993) 1.47
Impaired response of atrial natriuretic factor to high salt intake in persons prone to hypertension. N Engl J Med (1988) 1.46
Influence of diet on the "intestinal" component of serum alkaline phosphatase in people of different ABO blood groups and secretor status. Nature (1966) 1.44
Increased central body fat deposition precedes a significant rise in resting blood pressure in male offspring of essential hypertensive parents: a 5 year follow-up study. J Hypertens (2001) 1.40
Faecal immunoreactive lipase: a simple diagnostic test for cystic fibrosis. Eur J Pediatr (1998) 1.39
Sodium-volume factor, cardiovascular reactivity and hypotensive mechanism of diuretic therapy in mild hypertension associated with diabetes mellitus. Am J Med (1979) 1.30
Hemosuccus pancreaticus as a source of obscure upper gastrointestinal bleeding: three cases and literature review. Am J Gastroenterol (1995) 1.27
Lactulose in the treatment of portal-systemic encephalopathy. Report of a symposium. Gastroenterology (1970) 1.26
Measurement of mesenteric blood flow by duplex scanning. J Vasc Surg (1986) 1.24
Effect on aging on plasma renin and aldosterone in normal man. Kidney Int (1975) 1.23
Effects of antihypertensive therapy on serum lipoproteins. Hypertension (1983) 1.19
Alpha and beta adrenergic blockade with orally administered labetalol in hypertension. Studies on blood volume, plasma renin and aldosterone and catecholamine excretion. Am J Cardiol (1978) 1.19
Detection of Septata intestinalis in stool specimens and coprodiagnostic monitoring of successful treatment with albendazole. Clin Infect Dis (1994) 1.16
Blood levels and renal effects of atrial natriuretic peptide in normal man. J Clin Invest (1986) 1.13
Body sodium-blood volume state, aldosterone, and cardiovascular responsiveness after calcium entry blockade with nifedipine. Kidney Int (1985) 1.12
Curable hypertension with unilateral hydronephrosis. Studies on the role of circulating renin. Ann Intern Med (1977) 1.11
Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure. Kidney Int (1992) 1.09
Studies on fibrin monomer aggregation in congenital dysfibrinogenaemia (fibrinogen "Zürich"): separation of a pathological from a normal fibrin fraction. Br J Haematol (1969) 1.09
Effects of nitrendipine and other calcium antagonists on glucose metabolism in man. J Cardiovasc Pharmacol (1984) 1.07
Recurrent intrahepatic cholestasis of pregnancy. Report of six cases, and review of the literature. Medicine (Baltimore) (1967) 1.07
Altered insulin sensitivity, hyperinsulinemia, and dyslipidemia in individuals with a hypertensive parent. Am J Med (1991) 1.06
Reduction and elimination of systemic heparinization during cardiopulmonary bypass. J Thorac Cardiovasc Surg (1992) 1.06
Methicillin nephritis. Medicine (Baltimore) (1977) 1.05
Celiac and celiac-like mucosal changes of the small intestine. Gastroenterologia (1965) 1.05
Diastolic dysfunction precedes myocardial hypertrophy in the development of hypertension. Am J Hypertens (2001) 1.03
Increased ratio between serum beta- and alpha-lipoproteins during diuretic therapy: an adverse effect? Clin Sci Mol Med Suppl (1978) 1.03
Blood pressure effects of acute hypercalcemia. Studies in patients with chronic renal failure. Ann Intern Med (1972) 1.02
Sodium, renin, aldosterone, catecholamines, and blood pressure in diabetes mellitus. Kidney Int (1977) 1.01
Autonomic function tests as related to age and gender in normal man. Klin Wochenschr (1986) 1.00
Atrial natriuretic peptide protects against acute ischemic renal failure in the rat. J Clin Invest (1987) 0.99
Dysfibrinogenemia in a patient with primary hepatoma. First observation of an acquired abnormality of fibrin monomer aggregation. N Engl J Med (1969) 0.99
Acute hypercalcemic hypertension in man: role of hemodynamics, catecholamines, and renin. Kidney Int (1981) 0.99
Plasma renin activity and blood pressure in terminal renal failure. N Engl J Med (1971) 0.98
Ankylosing spondylitis and sarcoidosis--coincidence or association? Case report and review of the literature. Clin Rheumatol (1992) 0.98
Plasma renin and blood pressure during treatment with methyldopa. Am J Cardiol (1974) 0.98
Comparison of three colon cleansing methods: evaluation of a randomized clinical trial with 300 ambulatory patients. Endoscopy (1989) 0.98
Em2-ELISA for the follow-up of alveolar echinococcosis after complete surgical resection of liver lesions. Trans R Soc Trop Med Hyg (1990) 0.97
Treatment of chronic portal-systemic encephalopathy with lactulose. Report of six patients and review of the literature. Am J Med (1971) 0.96
Effect of sodium intake on plasma catecholamines in normal subjects. J Clin Endocrinol Metab (1979) 0.96
[Amodiaquine-induced agranulocytosis in malaria prevention: demonstration of an amodiaquine-induced cytotoxic antibody against granulocytes]. Schweiz Med Wochenschr (1983) 0.96
Pancreatic exocrine insufficiency and proteolytic enzymes in stool. A critical evaluation of a new diagnostic test in various forms of steatorrhea. Helv Med Acta (1966) 0.95
Calcitonin gene-related peptide is a stimulator of renin secretion. J Clin Invest (1988) 0.95
Increase in circulating insulin induced by atrial natriuretic peptide in normal humans. J Cardiovasc Pharmacol (1987) 0.95
Neutropenia after penicillins: toxic or immune-mediated? Klin Wochenschr (1981) 0.95
Mental disorders and criminal behaviour. Br J Psychiatry (1995) 0.94
A cell number-counting factor regulates group size in Dictyostelium by differentially modulating cAMP-induced cAMP and cGMP pulse sizes. J Biol Chem (2001) 0.94
Enhanced exercise-induced rise of aldosterone and vasopressin preceding mountain sickness. J Appl Physiol (1985) (1991) 0.94
Atrial natriuretic peptide in acute mountain sickness. J Appl Physiol (1985) (1988) 0.93
Effects of tyramine on blood pressure and plasma catecholamines in normal and hypertensive subjects. Klin Wochenschr (1982) 0.93
Insulin, insulin sensitivity and hypertension. J Hypertens (1990) 0.92
Plasma renin activity in patients with coarctation of the aorta. A comment of the pathogenesis prestenotic hypertension. Circulation (1969) 0.92
Impact of etiology on the painful early stage of chronic pancreatitis: a long-term prospective study. Z Gastroenterol (2005) 0.92
[The effect of diuretic therapy on serum lipoproteins: an undesirable effect?]. Schweiz Med Wochenschr (1979) 0.91
Age versus urinary sodium for judging renin, aldosterone, and catecholamine levels: studies in normal subjects and patients with essential hypertension. Kidney Int (1978) 0.91
Hypertension associated with tumors adjacent to renal arteries. Am J Med (1969) 0.91
Inhibition of hepatic demethylation of aminopyrine by oral contraceptive steroids in humans. Eur J Clin Invest (1978) 0.91
Relation of arterial pressure with body sodium, body potassium and plasma potassium in essential hypertension. Clin Sci (Lond) (1982) 0.90
Stimulation of renin secretion by potassium-channel activation with cromakalim. Eur J Clin Pharmacol (1989) 0.90
Increased serum low-density lipoprotein cholesterol in men treated short-term with the diuretic chlorthalidone. Metabolism (1980) 0.90
Norepinephrine clearance and pressor effect in normal and hypertensive man. Klin Wochenschr (1980) 0.90
A double-blind trial of synthetic salmon calcitonin in the treatment of acute pancreatitis. Scand J Gastroenterol (1979) 0.90
Antihypertensive agents, serum lipoproteins and glucose metabolism. Am J Cardiol (1991) 0.89
Diuretic treatment and serum lipoproteins: effects of tienilic acid and indapamide. Klin Wochenschr (1981) 0.89
Preclinical and manifest diabetes mellitus in young patients with Friedreich's ataxia: no evidence of immune process behind the islet cell destruction. Diabetologia (1989) 0.89
Mutational analysis of the first 14 exons of the adenomatous polyposis coli (APC) gene. Eur J Cancer (1994) 0.88
Reproducibility of insulin sensitivity measured by the minimal model method. Diabetologia (1991) 0.88
Effect of prostaglandin E1 on renin in the dog. Am J Physiol (1971) 0.87
[The effect of hydrochlorothiazide/amiloride alone or in combination with alpha-methyldopa on serum lipoproteins]. Schweiz Med Wochenschr (1981) 0.87
[Omeprazole/amoxicillin: improved eradication of Helicobacter pylori in smokers because of N-acetylcysteine]. Schweiz Med Wochenschr (1994) 0.87
Dysregulation of atrial natriuretic factor in hypertension-prone man. J Clin Endocrinol Metab (1990) 0.87
Dialysis treatment of acute chromium intoxication and comparative efficacy of peritoneal versus hemodialysis in chromium removal. Miner Electrolyte Metab (1982) 0.87
[Drug therapy in hypertension 1977. Empirical and rational viewpoints]. Schweiz Med Wochenschr (1978) 0.87
[Mesenterial anemia as a cause of jogging anemia?]. Schweiz Med Wochenschr (1986) 0.86
Depressor effects and release of atrial natriuretic peptide during norepinephrine or angiotensin II infusion in man. J Clin Endocrinol Metab (1986) 0.86
Catecholamines, sodium and renin in unilateral renal hypertension in man. Miner Electrolyte Metab (1982) 0.86
Platelet aggregation and beta-thromboglobulin levels in nephrotic patients with and without thrombosis. Clin Nephrol (1981) 0.86
Low molecular weight heparin (KABI 2165) as thromboprophylaxis in elective visceral surgery. A randomized, double-blind study versus unfractionated heparin. Thromb Haemost (1986) 0.86
Mental disorder and criminality: male schizophrenia. Schizophr Bull (1996) 0.86
[Lactate deficiency of the mucosa of the small intestine as the cause of certain forms of acquired milk intolerance in adults]. Helv Med Acta (1963) 0.86
Lasting improvement of renovascular hypertension by transluminal dilatation of atherosclerotic and nonatherosclerotic renal artery stenoses. A follow-up study. Circulation (1982) 0.85
Effect of acute and long-standing hypocalcemia on blood pressure and plasma renin activity in man. J Clin Endocrinol Metab (1974) 0.85
Body sodium-blood volume state in nonazotemic diabetes mellitus. Miner Electrolyte Metab (1982) 0.85
Increased ratio between changes in blood pressure and plasma norepinephrine in essential hypertension. J Clin Endocrinol Metab (1979) 0.85
Differential activation of cardiac and peripheral sympathetic nervous system by nifedipine: role of pharmacokinetics. J Am Coll Cardiol (1997) 0.85
Effects of calcium antagonists on glucose homeostasis and serum lipids in non-diabetic and diabetic subjects: a review. J Hypertens Suppl (1987) 0.85
Relationship between APC genotype, polyp distribution, and oral sulindac treatment in the colon and rectum of patients with familial adenomatous polyposis. Dis Colon Rectum (2001) 0.84
Pressor factors and cardiovascular pressor responsiveness in borderline hypertension. Hypertension (1981) 0.84
[Alveolar echinococcosis: therapy with surgery, chemotherapy or a combination of the two?]. Langenbecks Arch Chir (1992) 0.84
Norepinephrine-related mechanism in hypertension accompanying renal failure. Kidney Int (1985) 0.84
Pathogenesis and treatment of hypertension associated with diabetes. Horm Metab Res Suppl (1985) 0.84
Cephalosporin-induced cholestatic jaundice. Lancet (1982) 0.84
The mechanism of action of lactulose in portal-systemic encephalopathy. Non-ionic diffusion of ammonia in the canine colon. Rev Eur Etud Clin Biol (1971) 0.84
Blood pressure control in normotensive members of hypertensive families. Kidney Int (1986) 0.84
[Treatment of chronic porto-systemic encephalopathy with lactulose]. Schweiz Med Wochenschr (1969) 0.83
Pathogenic and therapeutic significance of cardiovascular pressor reactivity as related to plasma catecholamines in borderline and established essential hypertension. Clin Exp Hypertens (1980) 0.83